
Join to View Full Profile
601 5th St SSte 302Saint Petersburg, FL 33701
Phone+1 727-767-4176
Fax+1 727-767-4379
Dr. Sunkersett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California (San Francisco) School of MedicineFellowship, Blood & Bone Marrow Transplant, 2016 - 2017
- University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2013 - 2016
- Nicklaus Children's HospitalResidency, Pediatrics, 2010 - 2013
- Nova Southeastern University College of Osteopathic MedicineClass of 2010
Certifications & Licensure
- FL State License 2017 - 2026
- CA State License 2016 - 2018
- TX State License 2013 - 2017
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.Andrew E Place, Seth E Karol, Christopher J Forlenza, Todd M Cooper, Christopher Fraser
Pediatric Blood & Cancer. 2025-06-01 - Endoscopic Assessment and Serial Balloon Dilatation in a Toddler With Dyskeratosis Congenita-Hoyeraal-Hreidarsson Syndrome Following Bone Marrow Transplant: A Case Rep...Kurt Rodriguez, Ryan Shargo, Morgan Ekblad, Gauri Sunkersett, Sara Karjoo
JPGN Reports. 2023-05-01 - 9 citationsVenetoclax Penetrates the Blood Brain Barrier: A Pharmacokinetic Analysis in Pediatric Leukemia Patients.Mohamed Badawi, Rajeev Menon, Andrew E Place, Tammy Palenski, Gauri Sunkersett
Journal of Cancer. 2023-01-01
Press Mentions
- The U.S. Food and Drug Administration Approved the Use of IMBRUVICA for the Treatment of Pediatric Patients One Year and Older with cGVHD After Failure of One or More Lines of Systemic TherapyAugust 24th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: